These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 37188803

  • 1. Trends in Receipt of Adjuvant Chemotherapy and its Impact on Survival in Resected Biliary Tract Cancers.
    Rhodin KE, Liu A, Bartholomew A, Kramer R, Parameswaran A, Uronis H, Strickler J, Hsu D, Morse MA, Shah KN, Herbert G, Zani S, Nussbaum DP, Allen PJ, Lidsky ME.
    Ann Surg Oncol; 2023 Aug; 30(8):4813-4821. PubMed ID: 37188803
    [Abstract] [Full Text] [Related]

  • 2. R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer.
    Matull WR, Dhar DK, Ayaru L, Sandanayake NS, Chapman MH, Dias A, Bridgewater J, Webster GJ, Bong JJ, Davidson BR, Pereira SP.
    Liver Int; 2011 Jan; 31(1):99-107. PubMed ID: 20846273
    [Abstract] [Full Text] [Related]

  • 3. Surgical Resection Alone is Associated With Higher Long-Term Survival Than Multiagent Chemotherapy Alone for Patients With Localized Biliary Tract Cancers.
    Elshami M, Ammori JB, Hardacre JM, Selfridge JE, Bajor D, Mohamed A, Chakrabarti S, Mahipal A, Winter JM, Ocuin LM.
    J Surg Res; 2024 Mar; 295():705-716. PubMed ID: 38141457
    [Abstract] [Full Text] [Related]

  • 4. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
    Tran Cao HS, Zhang Q, Sada YH, Chai C, Curley SA, Massarweh NN.
    Cancer; 2018 Jan 01; 124(1):74-83. PubMed ID: 28841223
    [Abstract] [Full Text] [Related]

  • 5. Revolutionizing anti-HER2 therapies for extrahepatic cholangiocarcinoma and gallbladder cancer: Current advancements and future perspectives.
    Ten Haaft BH, Pedregal M, Prato J, Klümpen HJ, Moreno V, Lamarca A.
    Eur J Cancer; 2024 Mar 01; 199():113564. PubMed ID: 38266541
    [Abstract] [Full Text] [Related]

  • 6. Adjuvant Chemotherapy and Outcomes in Older Adult Patients With Biliary Tract Cancer.
    Gbolahan OB, Zhi X, Liu Y, Shah MM, Kooby DA, Alese OB.
    JAMA Netw Open; 2024 Jan 02; 7(1):e2351502. PubMed ID: 38206623
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
    Jansson H, Cornillet M, Björkström NK, Sturesson C, Sparrelid E.
    Eur J Surg Oncol; 2020 May 02; 46(5):804-810. PubMed ID: 31848078
    [Abstract] [Full Text] [Related]

  • 8. Survival outcome of patient with pT1N0 biliary tract cancer treated with surgery alone.
    Kagoura M, Kobayashi S, Kojima M, Kudo M, Sugimoto M, Konishi M, Gotohda N.
    Eur J Surg Oncol; 2024 Mar 02; 50(3):107980. PubMed ID: 38281442
    [Abstract] [Full Text] [Related]

  • 9. Comparative Genomic Analysis and Clinical Outcomes of BRAF-mutated Advanced Biliary Tract Cancers.
    Tang TY, Nichetti F, Kaplan B, Lonardi S, Pietrantonio F, Salvatore L, Vivaldi C, Rimassa L, de Braud F, Rizzato MD, Pavlick D, Chu R, Danner De Armas A, Sharaf R, Sokol E, Rodon Ahnert J, Ross JS, Javle M, Niger M.
    Clin Cancer Res; 2023 Dec 01; 29(23):4853-4862. PubMed ID: 37773629
    [Abstract] [Full Text] [Related]

  • 10. The epidemiological trends of biliary tract cancers in the United States of America.
    Jiang Y, Jiang L, Li F, Li Q, Yuan S, Huang S, Fu Y, Yan X, Chen J, Li H, Li S, Liu J.
    BMC Gastroenterol; 2022 Dec 29; 22(1):546. PubMed ID: 36581813
    [Abstract] [Full Text] [Related]

  • 11. Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study).
    Leone F, Marino D, Cereda S, Filippi R, Belli C, Spadi R, Nasti G, Montano M, Amatu A, Aprile G, Cagnazzo C, Fasola G, Siena S, Ciuffreda L, Reni M, Aglietta M.
    Cancer; 2016 Feb 15; 122(4):574-81. PubMed ID: 26540314
    [Abstract] [Full Text] [Related]

  • 12. Patterns of Failure and the Need for Biliary Intervention in Resected Biliary Tract Cancers After Chemoradiation.
    Dee EC, Freret ME, Horick N, Raldow AC, Goyal L, Zhu AX, Parikh AR, Ryan DP, Clark JW, Allen JN, Ferrone CR, Fernandez-Del Castillo C, Tanabe KK, Drapek LC, Hong TS, Qadan M, Wo JY.
    Ann Surg Oncol; 2020 Dec 15; 27(13):5161-5172. PubMed ID: 32740733
    [Abstract] [Full Text] [Related]

  • 13. A prospective feasibility study of one-year administration of adjuvant S-1 therapy for resected biliary tract cancer in a multi-institutional trial (Tokyo Study Group for Biliary Cancer: TOSBIC01).
    Itano O, Takemura Y, Kishida N, Tamagawa E, Shinozaki H, Ikeda K, Urakami H, Ei S, Hayatsu S, Suzuki K, Sakuragawa T, Ishii M, Shito M, Aiura K, Fujisaki H, Takano K, Matsui J, Minagawa T, Shinoda M, Kitago M, Abe Y, Yagi H, Oshima G, Hori S, Kitagawa Y.
    BMC Cancer; 2020 Jul 23; 20(1):688. PubMed ID: 32703191
    [Abstract] [Full Text] [Related]

  • 14. The efficacy and safety of 5-fluorouracil based adjuvant therapy in resected biliary tract cancer: A systematic review and meta-analysis.
    Song S, Yang W, Tian H, Gong S, Lei C, Lv K, Lu T, Cheng Q, Yang K, Guo T.
    Clin Res Hepatol Gastroenterol; 2022 Feb 23; 46(2):101788. PubMed ID: 34389530
    [Abstract] [Full Text] [Related]

  • 15. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
    Clements O, Eliahoo J, Kim JU, Taylor-Robinson SD, Khan SA.
    J Hepatol; 2020 Jan 23; 72(1):95-103. PubMed ID: 31536748
    [Abstract] [Full Text] [Related]

  • 16. A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder Cancer.
    Ozer M, Goksu SY, Sanford NN, Porembka M, Khurshid H, Ahn C, Maxwell MC, Beg MS, Kazmi SM.
    JAMA Netw Open; 2022 Feb 01; 5(2):e2146912. PubMed ID: 35171262
    [Abstract] [Full Text] [Related]

  • 17. Neoadjuvant Chemotherapy for Intrahepatic, Perihilar, and Distal Cholangiocarcinoma: a National Population-Based Comparative Cohort Study.
    Parente A, Kamarajah SK, Baia M, Tirotta F, Manzia TM, Hilal MA, Pawlik TM, White SA, Dahdaleh FS.
    J Gastrointest Surg; 2023 Apr 01; 27(4):741-749. PubMed ID: 36749556
    [Abstract] [Full Text] [Related]

  • 18. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
    Huang L, Chen W, Liang P, Hu W, Zhang K, Shen S, Chen J, Zhang Z, Chen B, Han Y, Meng F, DeMorrow S, Yin X, Lai J, Liang L.
    Dig Dis Sci; 2015 May 01; 60(5):1273-83. PubMed ID: 25487191
    [Abstract] [Full Text] [Related]

  • 19. Aspirin, Statins, Non-aspirin NSAIDs, Metformin, and the Risk of Biliary Cancer: A Swedish Population-Based Cohort Study.
    Marcano-Bonilla L, Schleck CD, Harmsen WS, Sadr-Azodi O, Borad MJ, Patel T, Petersen GM, Therneau TM, Roberts LR, Brusselaers N.
    Cancer Epidemiol Biomarkers Prev; 2022 Apr 01; 31(4):804-810. PubMed ID: 35086822
    [Abstract] [Full Text] [Related]

  • 20. Surgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer: a retrospective single-center study.
    Kato A, Shimizu H, Ohtsuka M, Yoshidome H, Yoshitomi H, Furukawa K, Takeuchi D, Takayashiki T, Kimura F, Miyazaki M.
    Ann Surg Oncol; 2013 Jan 01; 20(1):318-24. PubMed ID: 23149849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.